Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
17.31
+0.09 (0.52%)
At close: Nov 14, 2025, 4:00 PM EST
17.31
0.00 (0.00%)
After-hours: Nov 14, 2025, 4:00 PM EST
Simulations Plus Revenue
Simulations Plus had revenue of $20.36M in the quarter ending May 31, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to $80.38M, up 20.01% year-over-year. In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth.
Revenue (ttm)
$80.38M
Revenue Growth
+20.01%
P/S Ratio
4.32
Revenue / Employee
$325,437
Employees
247
Market Cap
348.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SLP News
- 13 days ago - SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 21 days ago - SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law - GlobeNewsWire
- 23 days ago - Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance - Business Wire
- 23 days ago - SLP STOCK NOTICE: Simulations Plus, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation - GlobeNewsWire
- 25 days ago - SLP SECURITIES NEWS: Simulations Plus, Inc. Faces a Securities Fraud Investigation after Stock Drops 26% -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 5 weeks ago - SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money - GlobeNewsWire
- 5 weeks ago - SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 5 weeks ago - SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law - GlobeNewsWire